Watchlist Manager

Watchlist

Price: 15.29 CNY 2%

Market Cap: ¥4.7B

	Suzhou MedicalSystem Technology Co Ltd SSE:603990	CN
	Chengdu Yunda Technology Co Ltd SZSE:300440	CN
	Tegma Gestao Logistica SA BOVESPA:TGMA3	BR
	Hyliion Holdings Corp NYSE:HYLN	US
	Oceaneering International Inc NYSE:OII	US

Income Statement

Currency: CNY

	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025	Dec-2025
Revenue
Interest Expense	2	0	0	0	3	0	0	2	4	3	4	4	5	5	5	7	7	7	8	7	7	6	5	4	4	4	9	17	49	66	76	86	72	58	0	0	0
Revenue	241 N/A	245 +2%	254 +4%	262 +3%	269 +3%	272 +1%	265 -3%	263 -1%	284 +8%	289 +2%	304 +5%	302 -1%	333 +10%	309 -7%	302 -2%	325 +8%	308 -5%	339 +10%	370 +9%	357 -4%	354 -1%	364 +3%	345 -5%	342 -1%	306 -11%	319 +5%	316 -1%	450 +42%	618 +37%	659 +7%	721 +9%	628 -13%	464 -26%	416 -10%	343 -18%	327 -5%	301 -8%
Gross Profit
Cost of Revenue	(75)	(73)	(72)	(71)	(71)	(78)	(69)	(77)	(73)	(81)	(88)	(85)	(93)	(93)	(93)	(97)	(85)	(98)	(122)	(118)	(107)	(114)	(100)	(100)	(90)	(101)	(97)	(214)	(500)	(552)	(687)	(633)	(413)	(353)	(222)	(177)	(120)
Gross Profit	166 N/A	172 +4%	182 +6%	191 +5%	198 +4%	194 -2%	196 +1%	186 -5%	212 +14%	208 -2%	216 +4%	217 +1%	240 +11%	215 -10%	209 -3%	228 +9%	223 -2%	241 +8%	249 +3%	238 -4%	247 +4%	250 +1%	245 -2%	241 -2%	215 -11%	218 +1%	218 +0%	236 +8%	118 -50%	106 -10%	34 -68%	(5) N/A	51 N/A	63 +23%	121 +91%	150 +24%	182 +22%
Operating Income
Operating Expenses	(139)	(143)	(140)	(140)	(143)	(137)	(149)	(150)	(151)	(146)	(152)	(150)	(171)	(156)	(151)	(161)	(165)	(158)	(168)	(178)	(199)	(199)	(194)	(188)	(178)	(199)	(253)	(294)	(354)	(297)	(253)	(258)	(204)	(268)	(253)	(205)	(155)
Selling, General & Administrative	(99)	(141)	(126)	(120)	(110)	(111)	(113)	(114)	(121)	(102)	(120)	(126)	(134)	(133)	(132)	(135)	(144)	(153)	(165)	(173)	(162)	(165)	(156)	(150)	(141)	(168)	(223)	(256)	(291)	(332)	(279)	(260)	(230)	(195)	(191)	(178)	(120)
Research & Development	(35)	0	0	(13)	(46)	0	0	(28)	(56)	(43)	(58)	(61)	(56)	(55)	(51)	(47)	(41)	(38)	(36)	(36)	(47)	(52)	(58)	(60)	(46)	(48)	(45)	(42)	(49)	(55)	(59)	(61)	(49)	(43)	(34)	(30)	(24)
Depreciation & Amortization	(5)	0	0	0	(11)	0	0	0	(12)	0	0	0	(14)	0	0	0	(13)	0	0	0	(11)	0	0	0	(9)	0	0	0	(16)	0	0	0	(23)	0	0	0	(21)
Other Operating Expenses	(0)	(2)	(14)	(6)	24	(26)	(36)	(9)	37	(0)	26	36	33	32	31	21	33	33	32	30	21	18	20	21	19	16	15	4	2	90	85	62	98	(30)	(28)	2	10
Operating Income	26 N/A	29 +10%	42 +46%	52 +23%	55 +6%	57 +4%	47 -18%	35 -24%	61 +73%	63 +3%	64 +2%	67 +5%	69 +3%	60 -13%	58 -3%	67 +15%	58 -14%	83 +43%	81 -2%	60 -26%	48 -20%	51 +5%	52 +3%	53 +2%	38 -29%	19 -49%	(35) N/A	(58) -65%	(236) -308%	(191) +19%	(219) -15%	(263) -20%	(153) +42%	(205) -34%	(133) +35%	(56) +58%	27 N/A
Pre-Tax Income
Interest Income Expense	(2)	(2)	(3)	(3)	(2)	(1)	(1)	(2)	(1)	(1)	(5)	(7)	(15)	(18)	(15)	(15)	(8)	(7)	(6)	(1)	3	4	5	4	6	7	4	(1)	(23)	(54)	(66)	(81)	(67)	(34)	(18)	0	(5)
Non-Reccuring Items	0	0	0	0	0	0	0	0	(0)	0	0	(0)	(0)	0	(0)	0	(1)	0	0	0	0	(0)	(0)	(0)	(0)	0	(0)	(0)	(3)	(0)	(0)	(0)	(34)	(0)	(0)	(0)	23
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(0)	0	0	0	(0)	0	0	0	(1)	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income	25	21	14	8	3	(3)	3	2	0	0	0	0	0	0	0	0	(0)	0	(0)	(0)	0	(0)	(0)	(0)	0	(2)	(3)	(3)	(0)	2	2	2	(0)	(1)	(1)	(1)	(0)
Pre-Tax Income	49 N/A	48 -3%	53 +11%	57 +8%	56 -3%	54 -4%	48 -10%	36 -26%	60 +70%	61 +1%	59 -4%	60 +3%	54 -11%	42 -23%	43 +2%	52 +21%	49 -6%	75 +55%	74 -1%	59 -21%	51 -13%	54 +5%	57 +5%	57 +1%	44 -24%	24 -45%	(33) N/A	(61) -84%	(262) -327%	(243) +7%	(284) -17%	(342) -21%	(254) +26%	(241) +5%	(151) +37%	(56) +63%	45 N/A
Net Income
Tax Provision	(4)	(4)	(5)	(4)	(4)	(4)	1	(2)	(5)	(6)	(9)	(7)	(7)	(7)	(7)	(9)	(7)	(9)	(9)	(8)	(8)	(8)	(10)	(11)	(8)	(9)	(9)	(10)	(3)	(2)	(1)	(1)	(24)	(23)	(21)	(19)	(4)
Income from Continuing Operations	45	44	49	53	51	49	49	33	55	56	50	54	47	35	36	43	42	66	65	51	44	46	47	46	35	15	(42)	(71)	(265)	(244)	(284)	(343)	(278)	(263)	(172)	(75)	41
Income to Minority Interest	0	0	0	0	0	0	0	0	0	1	1	1	(0)	(0)	(3)	(5)	(7)	(8)	(6)	(3)	(2)	(1)	(1)	(1)	(2)	(1)	(2)	(4)	(4)	(4)	(4)	(2)	(2)	(2)	(2)	(3)	(2)
Net Income (Common)	45 N/A	44 -3%	49 +11%	53 +9%	51 -3%	49 -3%	49 -1%	33 -32%	56 +67%	56 +1%	50 -10%	55 +9%	47 -15%	35 -26%	33 -5%	38 +15%	35 -6%	59 +66%	60 +2%	48 -20%	42 -12%	45 +6%	46 +2%	45 -1%	34 -26%	13 -60%	(44) N/A	(76) -71%	(269) -255%	(249) +8%	(288) -16%	(345) -20%	(279) +19%	(266) +5%	(175) +34%	(78) +55%	39 N/A
EPS (Diluted)	0.41 N/A	0.3 -27%	0.32 +7%	0.36 +12%	0.35 -3%	0.35 N/A	0.34 -3%	0.23 -32%	0.38 +65%	0.38 N/A	0.41 +8%	0.39 -5%	0.32 -18%	0.23 -28%	0.23 N/A	0.27 +17%	0.24 -11%	0.35 +46%	0.27 -23%	0.25 -7%	0.15 -40%	0.2 +33%	0.23 +15%	0.13 -43%	0.12 -8%	0.04 -67%	-0.13 N/A	-0.24 -85%	-0.88 -267%	-0.82 +7%	-0.92 -12%	-1.15 -25%	-0.92 +20%	-0.87 +5%	-0.54 +38%	-0.26 +52%	0.13 N/A

Income Statement Balance Sheet Cash Flow Statement

Suzhou MedicalSystem Technology Co Ltd
SSE:603990

Income Statement

Earnings Waterfall
Suzhou MedicalSystem Technology Co Ltd

Income Statement
Suzhou MedicalSystem Technology Co Ltd

See Also

Company

Help

Tools

Stocks

Suzhou MedicalSystem Technology Co Ltd SSE:603990

Income Statement

Earnings Waterfall Suzhou MedicalSystem Technology Co Ltd

Income Statement Suzhou MedicalSystem Technology Co Ltd

See Also

Company

Help

Tools

Stocks

Suzhou MedicalSystem Technology Co Ltd
SSE:603990

Earnings Waterfall
Suzhou MedicalSystem Technology Co Ltd

Income Statement
Suzhou MedicalSystem Technology Co Ltd